Ian Marks serves as Global Vice President for Life Sciences at Salesforce. With more than 25 years in the pharmaceutical and consumer healthcare industry, Marks has extensive experience delivering breakthrough innovations, leading disruptive initiatives, cultivating unorthodox partnerships, and building strategic capabilities that improve patients' lives and drive business value.
COVID-19 put a halt on elective procedures in order to conserve resources and reduce the spread of the virus. Now, medtech organizations must change how they engage, sell to, and support healthcare providers.
